Published in Cancer Chemother Pharmacol on January 01, 1996
Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol (2000) 3.57
DNA interstrand crosslink repair during G1 involves nucleotide excision repair and DNA polymerase zeta. EMBO J (2006) 1.89
Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair. Mol Cell Biol (2001) 1.76
Nucleotide excision repair- and polymerase eta-mediated error-prone removal of mitomycin C interstrand cross-links. Mol Cell Biol (2003) 1.76
hMutSbeta is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro. Mol Cell Biol (2002) 1.58
Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. Genes Dev (2011) 1.46
Interstrand cross-links induce DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts. Mol Cell Biol (1999) 1.39
Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells. DNA Repair (Amst) (2010) 1.30
Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway. DNA Repair (Amst) (2007) 1.26
Mammalian nucleotide excision repair proteins and interstrand crosslink repair. Environ Mol Mutagen (2010) 1.17
Initiation of DNA interstrand cross-link repair in mammalian cells. Environ Mol Mutagen (2010) 1.09
Triplex targeted genomic crosslinks enter separable deletion and base substitution pathways. Nucleic Acids Res (2005) 1.07
Orchestrating the nucleases involved in DNA interstrand cross-link (ICL) repair. Cell Cycle (2011) 1.00
Repair of DNA interstrand cross-links during S phase of the mammalian cell cycle. Environ Mol Mutagen (2010) 0.99
Nucleotide excision repair of a DNA interstrand cross-link produces single- and double-strand breaks. Biochemistry (2010) 0.97
Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy. Pharmacogenomics (2009) 0.92
Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer. J Cancer Res Clin Oncol (2010) 0.92
The ERCC1 and ERCC4 (XPF) genes and gene products. Gene (2015) 0.91
Unique tissue-specific level of DNA nucleotide excision repair in primary human mammary epithelial cultures. Exp Cell Res (2003) 0.91
The differences between ICL repair during and outside of S phase. Trends Biochem Sci (2013) 0.88
Differential processing of UV mimetic and interstrand crosslink damage by XPF cell extracts. Nucleic Acids Res (2000) 0.86
Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck. PLoS One (2012) 0.85
Involvement of the Ras/extracellular signal-regulated kinase signalling pathway in the regulation of ERCC-1 mRNA levels by insulin. Biochem J (1998) 0.83
Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin. Br J Cancer (1999) 0.81
Unscheduled DNA synthesis: a functional assay for global genomic nucleotide excision repair. Methods Mol Biol (2005) 0.80
Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin. Oncol Lett (2012) 0.79
XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection. Int J Cancer (2013) 0.79
Unscheduled DNA synthesis: the clinical and functional assay for global genomic DNA nucleotide excision repair. Methods Mol Biol (2014) 0.76
Questionnaire on the perceptions of patients about total hip replacement. J Bone Joint Surg Br (1996) 7.44
Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg Br (1998) 7.20
RJR Nabisco's cartoon camel promotes camel cigarettes to children. JAMA (1991) 7.07
Quantitation of intraepithelial lymphocytes in human jejunum. Gut (1971) 6.18
Variations in mortality after emergency laparotomy: the first report of the UK Emergency Laparotomy Network. Br J Anaesth (2012) 4.61
Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science (1993) 3.88
XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol Cell (1998) 3.73
Human creatine kinase genes on chromosomes 15 and 19, and proximity of the gene for the muscle form to the genes for apolipoprotein C2 and excision repair. Am J Hum Genet (1988) 3.41
The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J (1990) 3.21
Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest (1994) 3.16
Repulsive axon guidance: Abelson and Enabled play opposing roles downstream of the roundabout receptor. Cell (2000) 2.88
The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell (1995) 2.78
Validation of the Edinburgh Postnatal Depression Scale (EPDS) in non-postnatal women. J Affect Disord (1996) 2.62
Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc Natl Acad Sci U S A (1995) 2.48
Pricing strategy to promote fruit and vegetable purchase in high school cafeterias. J Am Diet Assoc (1997) 2.45
Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J (1990) 2.38
A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry (1993) 2.38
Fatal pulmonary emboli in hospitalized patients. An autopsy study. Arch Intern Med (1988) 2.37
Structure and function of the small intestine in dermatitis herpetiformis. Br J Dermatol (1967) 2.20
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant (2008) 2.10
Operational criteria for the determination of suicide. J Forensic Sci (1988) 2.09
Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res (1990) 2.07
Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int (1995) 2.06
A long-range restriction map of the human chromosome 19q13 region: close physical linkage between CKMM and the ERCC1 and ERCC2 genes. Am J Hum Genet (1990) 1.94
Correction of a nucleotide-excision-repair mutation by human chromosome 19 in hamster-human hybrid cells. Somat Cell Mol Genet (1985) 1.91
Intestinal tuberculosis: experience at a Canadian teaching institution. Am J Med (1977) 1.78
HIV seroprevalence in a London same-day testing clinic. AIDS (1994) 1.78
Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics (1995) 1.74
Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery (1996) 1.67
Retracted Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science (2001) 1.67
Is dieting good for you?: Prevalence, duration and associated weight and behaviour changes for specific weight loss strategies over four years in US adults. Int J Obes Relat Metab Disord (1999) 1.67
Dieting status and its relationship to eating and physical activity behaviors in a representative sample of US adolescents. J Am Diet Assoc (1998) 1.67
Membrane binding of peptides containing both basic and aromatic residues. Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS. Biochemistry (2000) 1.67
Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen. J Clin Invest (1990) 1.64
Adult coeliac disease in hyposplenic patients. Lancet (1970) 1.63
Premutation allele pool in myotonic dystrophy type 2. Neurology (2008) 1.61
Comparison of measures to assess outcomes in total hip replacement surgery. Qual Health Care (1996) 1.60
The intrinsic electrostatic potential and the intermediate ring of charge in the acetylcholine receptor channel. J Gen Physiol (2000) 1.56
TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. Proc Natl Acad Sci U S A (1991) 1.53
Risks and benefits of prophylaxis against venous thromboembolism in orthopaedic surgery. J Bone Joint Surg Br (2000) 1.53
Febrile urinary infection in the institutionalized elderly. Am J Med (1996) 1.47
The significance of spinal cord compression as the initial manifestation of lymphoma. Neurosurgery (1993) 1.47
Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int (1996) 1.46
Adrenal myelolipomatous nodules mimicking adrenal neoplasms: report of three cases. Can J Surg (1989) 1.43
Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J Biol Chem (1995) 1.42
Computed tomographic colonography (CTC) performance: one-year clinical follow-up. Clin Radiol (2006) 1.42
An outburst from a massive star 40 days before a supernova explosion. Nature (2013) 1.42
Urinary antibody level and survival in bacteriuric institutionalized older subjects. J Am Geriatr Soc (1998) 1.40
A new polymorphic probe which defines the region of chromosome 19 containing the myotonic dystrophy locus. Am J Hum Genet (1990) 1.39
The value of an elastic tissue stain in detecting venous invasion in colorectal cancer. J Clin Pathol (2004) 1.37
Natural history of anterior knee pain: a 14- to 20-year follow-up of nonoperative management. J Pediatr Orthop (1998) 1.36
Assignment of a human DNA-repair gene associated with sister-chromatid exchange to chromosome 19. Mutat Res (1986) 1.34
Imputation strategies for missing data in a school-based multi-centre study: the Pathways study. Stat Med (2001) 1.33
Ex vivo expansion of umbilical cord blood. Cytotherapy (2005) 1.32
Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. Health Technol Assess (1998) 1.32
Evidence for the validity of a patient-based instrument for assessment of outcome after revision hip replacement. J Bone Joint Surg Br (2001) 1.30
Loss to follow-up: does it matter? Lancet (1995) 1.30
Hypermutable myotonic dystrophy CTG repeats in transgenic mice. Nat Genet (1997) 1.29
Dramatic, expansion-biased, age-dependent, tissue-specific somatic mosaicism in a transgenic mouse model of triplet repeat instability. Hum Mol Genet (2000) 1.25
Prognosis in colon cancer: a pathologic reassessment. Arch Surg (1975) 1.25
Subchronic toxicity of chlorine dioxide and related compounds in drinking water in the nonhuman primate. Environ Health Perspect (1982) 1.23
Interpretation of patient-reported outcomes for hip and knee replacement surgery: identification of thresholds associated with satisfaction with surgery. J Bone Joint Surg Br (2012) 1.22
Complementation of repair gene mutations on the hemizygous chromosome 9 in CHO: a third repair gene on human chromosome 19. Genomics (1989) 1.22
Isolation of human transcribed sequences from human-rodent somatic cell hybrids. Science (1989) 1.21
High-frequency transformation of human repair-deficient cell lines by an Epstein-Barr virus-based cDNA expression vector. Gene (1991) 1.20
Provision of primary total hip replacement surgery. Lancet (1999) 1.20
Identification of nucleotide-excision-repair genes on human chromosomes 2 and 13 by functional complementation in hamster-human hybrids. Somat Cell Mol Genet (1987) 1.19
MARCKS, membranes, and calmodulin: kinetics of their interaction. Biochim Biophys Acta (1998) 1.19
Cloning and characterization of a mouse 3-methyladenine/7-methyl-guanine/3-methylguanine DNA glycosylase cDNA whose gene maps to chromosome 11. Carcinogenesis (1993) 1.17
A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther (1997) 1.16
Evolution of imaging for abdominal perforation. Ann R Coll Surg Engl (2010) 1.15
Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene. Genomics (1998) 1.14
ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells. Int J Cancer (2000) 1.13
Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood (1994) 1.12
Population strategies to enhance physical activity: the Minnesota Heart Health Program. Acta Med Scand Suppl (1986) 1.12
Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia. J Invest Dermatol (1998) 1.11
Dual Alu polymerase chain reaction primers and conditions for isolation of human chromosome painting probes from hybrid cells. Cancer Genet Cytogenet (1993) 1.11
Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J Exp Med (1995) 1.11
Characterization of a cell line (SW756) derived from a human squamous carcinoma of the uterine cervix. In Vitro (1982) 1.10
Net1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer (2006) 1.09
High-frequency structural gene deletion as the basis for functional hemizygosity of the adenine phosphoribosyltransferase locus in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1983) 1.09
Prospective study of decubitus ulcers in two long term care facilities. Can J Infect Control (1994) 1.08
The North Staffordshire Maternity Hospital prospective study of pregnancy-associated depression. J Psychosom Obstet Gynaecol (2000) 1.08
Make your practice irresistible to health plans. Med Econ (1994) 1.07
The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemia. Leukemia (1987) 1.07
Factors affecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival model. Ann Surg Oncol (2000) 1.06
Kinetics of interaction of the myristoylated alanine-rich C kinase substrate, membranes, and calmodulin. J Biol Chem (1997) 1.06
Is there a place for shelf acetabuloplasty in the management of adult acetabular dysplasia? A survivorship study. J Bone Joint Surg Br (2005) 1.06
Cloning of the human SIX1 gene and its assignment to chromosome 14. Genomics (1996) 1.05
Expression of human adenosine deaminase after fusion of adenosine deaminase-deficient cells with mouse fibroblasts. Proc Natl Acad Sci U S A (1978) 1.05
Electrophoretic shift mutants in Chinese hamster ovary cells: evidence for genetic diploidy. Proc Natl Acad Sci U S A (1978) 1.05
KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts. Leukemia (1995) 1.05
XPC interacts with both HHR23B and HHR23A in vivo. Mutat Res (1997) 1.04
Dermatitis herpetiformis in two patients with idiopathic steatorrhoea (adult coeliac disease). Br Med J (1968) 1.04
HEN1 and HEN2: a subgroup of basic helix-loop-helix genes that are coexpressed in a human neuroblastoma. Proc Natl Acad Sci U S A (1992) 1.04
Three linked enzyme loci in fishes: implications in the evolution of vertebrate chromosomes. Genetics (1977) 1.04
Characterization of the DiFi rectal carcinoma cell line derived from a familial adenomatous polyposis patient. In Vitro Cell Dev Biol (1993) 1.02
Cloning the Drosophila homolog of the xeroderma pigmentosum complementation group C gene reveals homology between the predicted human and Drosophila polypeptides and that encoded by the yeast RAD4 gene. Nucleic Acids Res (1994) 1.02